COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
USA - NASDAQ:COLL - US19459J1043 - Common Stock
35.75 USD
-0.41 (-1.13%)
35.751 USD
0 (0%)
Overall COLL gets a fundamental rating of 6 out of 10. We evaluated COLL against 197 industry peers in the Pharmaceuticals industry. While COLL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. COLL scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year COLL was profitable.
In the past year COLL had a positive cash flow from operations.
COLL had positive earnings in 4 of the past 5 years.
In the past 5 years COLL always reported a positive cash flow from operatings.
1.2 Ratios
COLL's Return On Assets of 2.28% is amongst the best of the industry. COLL outperforms 84.26% of its industry peers.
COLL has a Return On Equity of 15.62%. This is amongst the best in the industry. COLL outperforms 89.34% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.69%, COLL belongs to the top of the industry, outperforming 84.26% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for COLL is below the industry average of 15.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.28% | ||
| ROE | 15.62% | ||
| ROIC | 7.69% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
Looking at the Profit Margin, with a value of 5.13%, COLL belongs to the top of the industry, outperforming 83.76% of the companies in the same industry.
COLL's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 18.35%, COLL belongs to the best of the industry, outperforming 87.31% of the companies in the same industry.
COLL's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 56.69%, COLL is doing good in the industry, outperforming 65.99% of the companies in the same industry.
In the last couple of years the Gross Margin of COLL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.35% | ||
| PM (TTM) | 5.13% | ||
| GM | 56.69% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so COLL is still creating some value.
The number of shares outstanding for COLL has been reduced compared to 1 year ago.
COLL has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, COLL has an improved debt to assets ratio.
2.2 Solvency
COLL has an Altman-Z score of 1.14. This is a bad value and indicates that COLL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.14, COLL perfoms like the industry average, outperforming 59.90% of the companies in the same industry.
COLL has a debt to FCF ratio of 4.08. This is a neutral value as COLL would need 4.08 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.08, COLL belongs to the top of the industry, outperforming 86.80% of the companies in the same industry.
COLL has a Debt/Equity ratio of 3.27. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.27, COLL is doing worse than 79.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 4.08 | ||
| Altman-Z | 1.14 |
ROIC/WACC0.79
WACC9.68%
2.3 Liquidity
A Current Ratio of 1.18 indicates that COLL should not have too much problems paying its short term obligations.
COLL's Current ratio of 1.18 is on the low side compared to the rest of the industry. COLL is outperformed by 76.65% of its industry peers.
A Quick Ratio of 1.10 indicates that COLL should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.10, COLL is doing worse than 72.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
COLL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.19%, which is quite impressive.
Measured over the past years, COLL shows a very strong growth in Earnings Per Share. The EPS has been growing by 154.78% on average per year.
COLL shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.61%.
The Revenue has been growing by 16.31% on average over the past years. This is quite good.
EPS 1Y (TTM)48.19%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%3.7%
Revenue 1Y (TTM)22.61%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%29.41%
3.2 Future
COLL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.42% yearly.
Based on estimates for the next years, COLL will show a small growth in Revenue. The Revenue will grow by 3.17% on average per year.
EPS Next Y30.62%
EPS Next 2Y14.84%
EPS Next 3Y4.88%
EPS Next 5Y4.42%
Revenue Next Year20.25%
Revenue Next 2Y11.18%
Revenue Next 3Y4.61%
Revenue Next 5Y3.17%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 5.46, the valuation of COLL can be described as very cheap.
COLL's Price/Earnings ratio is rather cheap when compared to the industry. COLL is cheaper than 95.94% of the companies in the same industry.
When comparing the Price/Earnings ratio of COLL to the average of the S&P500 Index (27.38), we can say COLL is valued rather cheaply.
A Price/Forward Earnings ratio of 4.20 indicates a rather cheap valuation of COLL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 96.95% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, COLL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.46 | ||
| Fwd PE | 4.2 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, COLL is valued cheaper than 98.98% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 96.45% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.58 | ||
| EV/EBITDA | 4.75 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of COLL may justify a higher PE ratio.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y4.88%
5. Dividend
5.1 Amount
No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
35.75
-0.41 (-1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners117.03%
Inst Owner Change-2.57%
Ins Owners1.55%
Ins Owner Change2.04%
Market Cap1.13B
Analysts81.82
Price Target45.49 (27.24%)
Short Float %13.98%
Short Ratio10.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.92%
Min EPS beat(2)1.88%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)3.95%
Min EPS beat(4)-0.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)9
Avg EPS beat(12)-6.79%
EPS beat(16)9
Avg EPS beat(16)-27.3%
Revenue beat(2)2
Avg Revenue beat(2)1.62%
Min Revenue beat(2)1.34%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)0.71%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.9%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)7
Avg Revenue beat(16)-4.84%
PT rev (1m)0.9%
PT rev (3m)3.72%
EPS NQ rev (1m)-6.15%
EPS NQ rev (3m)0.12%
EPS NY rev (1m)0%
EPS NY rev (3m)19.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.46 | ||
| Fwd PE | 4.2 | ||
| P/S | 1.59 | ||
| P/FCF | 5.58 | ||
| P/OCF | 5.53 | ||
| P/B | 4.85 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.75 |
EPS(TTM)6.55
EY18.32%
EPS(NY)8.51
Fwd EY23.79%
FCF(TTM)6.41
FCFY17.92%
OCF(TTM)6.46
OCFY18.07%
SpS22.44
BVpS7.37
TBVpS-22.1
PEG (NY)0.18
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.28% | ||
| ROE | 15.62% | ||
| ROCE | 11.5% | ||
| ROIC | 7.69% | ||
| ROICexc | 9.58% | ||
| ROICexgc | N/A | ||
| OM | 18.35% | ||
| PM (TTM) | 5.13% | ||
| GM | 56.69% | ||
| FCFM | 28.54% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.27 | ||
| Debt/FCF | 4.08 | ||
| Debt/EBITDA | 2.22 | ||
| Cap/Depr | 0.79% | ||
| Cap/Sales | 0.24% | ||
| Interest Coverage | 1.9 | ||
| Cash Conversion | 59.64% | ||
| Profit Quality | 556.38% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 1.14 |
F-Score5
WACC9.68%
ROIC/WACC0.79
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.19%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%3.7%
EPS Next Y30.62%
EPS Next 2Y14.84%
EPS Next 3Y4.88%
EPS Next 5Y4.42%
Revenue 1Y (TTM)22.61%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%29.41%
Revenue Next Year20.25%
Revenue Next 2Y11.18%
Revenue Next 3Y4.61%
Revenue Next 5Y3.17%
EBIT growth 1Y-36.29%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year147.2%
EBIT Next 3Y28.36%
EBIT Next 5Y16.08%
FCF growth 1Y-14.2%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y-13.96%
OCF growth 3Y25.54%
OCF growth 5Y49.12%